Foundation Medicine, Inc. (NASDAQ:FMI) is on recovery track with 266.08% gain from a 1-year low price of $17.10. The company added 17.67% to attain the price of $62.6 on 12/01/2017. Throughout the recent session, the prices were hovering between $57.91 and $67.4. These shares are -35.03% up from its target price of $40.67 and the current market capitalization stands at $2.16B. The recent change has given its price a 37.88% lead over SMA 50 and 11.89% lead over its 52-week high. The stock witnessed 48.87% gains, 56.89% gains and 54.19% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found FMI’s volatility during a week at 7% and during a month it has been found around 6.34%.Foundation Medicine, Inc. (FMI) Top Holders
Institutional investors currently hold around $742 million or 33% in FMI stock. Look at its top three institutional owners. Gilder Gagnon Howe & Co Llc owns $95.31 million in Foundation Medicine, Inc., which represents roughly 4.41% of the company’s market cap and approximately 12.85% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 1,442,697 shares of the stock are valued at $90.31 million. The third largest holder is Chevy Chase Trust Holdings, Inc., which currently holds $66.3 million worth of this stock and that ownership represents nearly 3.07% of its market capitalization.Foundation Medicine, Inc. 13F Filings
At the end of 9/30/2017 reporting period, 44 institutional holders increased their position in Foundation Medicine, Inc. (NASDAQ:FMI) by some 829,647 shares, 35 decreased positions by 452,933 and 30 held positions by 10,564,348. That puts total institutional holdings at 11,846,928 shares, according to SEC filings. The stock grabbed 6 new institutional investments totaling 385,158 shares while 13 institutional investors sold out their entire positions totaling 278,047 shares.Foundation Medicine, Inc. (NASDAQ:FMI) Insider Trades
Multiple company employees have indulged in significant insider trading. Foundation Medicine, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that CFO Ryan Jason has sold 9,731 shares of Foundation Medicine, Inc. (FMI) in trading session dated Nov. 02, 2017. These shares are worth $486,550 and were traded at $50 each. The SEC filing shows that Kafka Steven J. performed a sale of 3,361 shares. The President & COO disposed these shares by way of transaction on Oct. 13, 2017. The company’s shares were given away at $44.62 per share worth to an income of some $149,968 on account of Kafka Steven J..
CFO, Ryan Jason, sold 1,152 common shares of Foundation Medicine, Inc. (FMI) in the open market. In a transaction dated Oct. 12, 2017, the shares were put up for sale at an average price of $45.05, raking in a sum of $51,898. After this sale, 62,332 common shares of FMI are directly owned by the insider, with total stake valued at $3,901,983.
In the transaction dated Oct. 02, 2017, the great number of shares disposed came courtesy the SVP and General Counsel; Hesslein Robert W. disposed a total of 2,165 shares at an average price of $38.8, amounting to approximately $84,002. The insider now directly owns 118,228 shares worth $7,401,073.